239101-33-8C[C@]1(C(=O)O)CSC(c2ccc(O)cc2O)=N1OEUUFNIKLCFNLN-LLVKDONJSA-NDeferitrin is under investigation in clinical trial NCT00069862 (Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-thalassemia).
239101-33-8VerwendenDeferitrin is a tridentate oral chelator intended for use in the primary treatment of iron overload resulting from transfusion therapy.
Wird geladen…
DTXSID901351209CHEMBL432481